ScoreWhy is Ocuphire Pharma, Inc. ?
1
Poor Management Efficiency with a low ROE of 9.08%
- The company has been able to generate a Return on Equity (avg) of 9.08% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 6 consecutive quarters
- INTEREST(9M) At USD 1.44 MM has Grown at inf%
- OPERATING CASH FLOW(Y) Lowest at USD -32.86 MM
- NET SALES(Q) At USD 3.08 MM has Fallen at -20.13%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 295.50%, its profits have fallen by -26.7%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -6.33% over the previous quarter and currently hold 5.34% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ocuphire Pharma, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Ocuphire Pharma, Inc.
313.51%
2.07
76.45%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
66.31%
EBIT Growth (5y)
-225.91%
EBIT to Interest (avg)
-9.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.52
Sales to Capital Employed (avg)
0.77
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
42.37%
ROCE (avg)
166.10%
ROE (avg)
9.08%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
61.88
EV to EBIT
-9.13
EV to EBITDA
-9.15
EV to Capital Employed
-14.28
EV to Sales
23.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-577.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET SALES(9M)
At USD 10.33 MM has Grown at 54.42%
NET PROFIT(HY)
Higher at USD -16.27 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -498.53 %
RAW MATERIAL COST(Y)
Fallen by -9,958% (YoY
-14What is not working for the Company
INTEREST(9M)
At USD 1.44 MM has Grown at inf%
OPERATING CASH FLOW(Y)
Lowest at USD -32.86 MM
NET SALES(Q)
At USD 3.08 MM has Fallen at -20.13%
NET PROFIT(9M)
At USD -27.26 MM has Grown at -21.74%
ROCE(HY)
Lowest at -338.75%
Here's what is working for Ocuphire Pharma, Inc.
Net Profit
Higher at USD -16.27 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at -498.53 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -9,958% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Ocuphire Pharma, Inc.
Interest
At USD 1.44 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
At USD 3.08 MM has Fallen at -20.13%
over average net sales of the previous four periods of USD 3.86 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Operating Cash Flow
Lowest at USD -32.86 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
